Neo Ivy Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Neo Ivy Capital Management’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$810K	Buy
2022 Q4	$188K	Buy
2022 Q2	–	Sell
2022 Q1	$8K	Buy
2021 Q3	–	Sell
2021 Q2	$277K	Buy
2021 Q1	$147K	Buy